CCL17 and Alzheimer disease: AD is a Th2-dominant inflammatory skin disease and an abnormal expression of Th2 chemokines such as TARC/CCL17 (thymus and activation-regulated chemokine) and MDC/CCL22 (macrophage-derived chemokine) in keratinocytes were observed at the inflammatory site of epidermis [28].